213 related articles for article (PubMed ID: 37619806)
1. In situ hydrogel containing diazepam-loaded nanostructured lipid carriers (DZP-NLC) for nose-to-brain delivery: development, characterization and deposition studies in a 3D-printed human nasal cavity model.
Pina Costa C; Nižić Nodilo L; Silva R; Martins E; Zadravec D; Kalogjera L; Nuno Moreira J; Manuel Sousa Lobo J; Hafner A; Catarina Silva A
Int J Pharm; 2023 Sep; 644():123345. PubMed ID: 37619806
[TBL] [Abstract][Full Text] [Related]
2. Thermosensitive in situ hydrogels of rivastigmine-loaded lipid-based nanosystems for nose-to-brain delivery: characterisation, biocompatibility, and drug deposition studies.
Cunha S; Swedrowska M; Bellahnid Y; Xu Z; Sousa Lobo JM; Forbes B; Silva AC
Int J Pharm; 2022 May; 620():121720. PubMed ID: 35413397
[TBL] [Abstract][Full Text] [Related]
3. Quality by design (QbD) optimization of diazepam-loaded nanostructured lipid carriers (NLC) for nose-to-brain delivery: Toxicological effect of surface charge on human neuronal cells.
Costa CP; Cunha S; Moreira JN; Silva R; Gil-Martins E; Silva V; Azevedo L; Peixoto AF; Sousa Lobo JM; Silva AC
Int J Pharm; 2021 Sep; 607():120933. PubMed ID: 34324988
[TBL] [Abstract][Full Text] [Related]
4. Double Optimization of Rivastigmine-Loaded Nanostructured Lipid Carriers (NLC) for Nose-to-Brain Delivery Using the Quality by Design (QbD) Approach: Formulation Variables and Instrumental Parameters.
Cunha S; Costa CP; Loureiro JA; Alves J; Peixoto AF; Forbes B; Sousa Lobo JM; Silva AC
Pharmaceutics; 2020 Jun; 12(7):. PubMed ID: 32605177
[TBL] [Abstract][Full Text] [Related]
5. Improving Drug Delivery for Alzheimer's Disease Through Nose-to-Brain Delivery Using Nanoemulsions, Nanostructured Lipid Carriers (NLC) and in situ Hydrogels.
Cunha S; Forbes B; Sousa Lobo JM; Silva AC
Int J Nanomedicine; 2021; 16():4373-4390. PubMed ID: 34234432
[TBL] [Abstract][Full Text] [Related]
6. An In Vitro Evaluation of the Potential Neuroprotective Effects of Intranasal Lipid Nanoparticles Containing Astaxanthin Obtained from Different Sources: Comparative Studies.
Torres J; Pereira JM; Marques-Oliveira R; Costa I; Gil-Martins E; Silva R; Remião F; Peixoto AF; Sousa Lobo JM; Silva AC
Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111521
[TBL] [Abstract][Full Text] [Related]
7. A Cell-Based Nasal Model for Screening the Deposition, Biocompatibility, and Transport of Aerosolized PLGA Nanoparticles.
Maaz A; Blagbrough IS; De Bank PA
Mol Pharm; 2024 Mar; 21(3):1108-1124. PubMed ID: 38333983
[TBL] [Abstract][Full Text] [Related]
8. Mucoadhesive nanostructured lipid carriers as a cannabidiol nasal delivery system for the treatment of neuropathic pain.
Matarazzo AP; Elisei LMS; Carvalho FC; Bonfílio R; Ruela ALM; Galdino G; Pereira GR
Eur J Pharm Sci; 2021 Apr; 159():105698. PubMed ID: 33406408
[TBL] [Abstract][Full Text] [Related]
9. Personalized Medicine in Nasal Delivery: The Use of Patient-Specific Administration Parameters To Improve Nasal Drug Targeting Using 3D-Printed Nasal Replica Casts.
Warnken ZN; Smyth HDC; Davis DA; Weitman S; Kuhn JG; Williams RO
Mol Pharm; 2018 Apr; 15(4):1392-1402. PubMed ID: 29485888
[TBL] [Abstract][Full Text] [Related]
10. Nose-To-Brain Delivery of PLGA-Diazepam Nanoparticles.
Sharma D; Sharma RK; Sharma N; Gabrani R; Sharma SK; Ali J; Dang S
AAPS PharmSciTech; 2015 Oct; 16(5):1108-21. PubMed ID: 25698083
[TBL] [Abstract][Full Text] [Related]
11. Development of Atomoxetine-Loaded NLC In Situ Gel for Nose-to-Brain Delivery: Optimization, In Vitro, and Preclinical Evaluation.
Mohanty D; Alsaidan OA; Zafar A; Dodle T; Gupta JK; Yasir M; Mohanty A; Khalid M
Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514171
[TBL] [Abstract][Full Text] [Related]
12. Nose-to-brain delivery of sumatriptan-loaded nanostructured lipid carriers: preparation, optimization, characterization and pharmacokinetic evaluation.
Masjedi M; Azadi A; Heidari R; Mohammadi-Samani S
J Pharm Pharmacol; 2020 Oct; 72(10):1341-1351. PubMed ID: 32579251
[TBL] [Abstract][Full Text] [Related]
13. Thermo-reversible in situ forming implant with nanostructured lipid carriers (NLC) as a delivery system for the administration of estradiol valerate.
Pineda-Hernández MT; Pérez-Urizar JT; Ganem-Rondero A
Drug Deliv Transl Res; 2020 Oct; 10(5):1393-1402. PubMed ID: 31942699
[TBL] [Abstract][Full Text] [Related]
14. Development and characterization of nanostructured lipid carriers based chitosan thermosensitive hydrogel for delivery of dexamethasone.
Tan G; Yu S; Li J; Pan W
Int J Biol Macromol; 2017 Oct; 103():941-947. PubMed ID: 28545971
[TBL] [Abstract][Full Text] [Related]
15. Agranulocytosis-Protective Olanzapine-Loaded Nanostructured Lipid Carriers Engineered for CNS Delivery: Optimization and Hematological Toxicity Studies.
Gadhave DG; Tagalpallewar AA; Kokare CR
AAPS PharmSciTech; 2019 Jan; 20(1):22. PubMed ID: 30604305
[TBL] [Abstract][Full Text] [Related]
16. Design and characterization of Nanostructured lipid carriers (NLC) and Nanostructured lipid carrier-based hydrogels containing Passiflora edulis seeds oil.
Krambeck K; Silva V; Silva R; Fernandes C; Cagide F; Borges F; Santos D; Otero-Espinar F; Lobo JMS; Amaral MH
Int J Pharm; 2021 May; 600():120444. PubMed ID: 33713760
[TBL] [Abstract][Full Text] [Related]
17. Topical Nanostructured Lipid Carrier Based Hydrogel of Mometasone Furoate for the Treatment of Psoriasis.
Kaur N; Sharma K; Bedi N
Pharm Nanotechnol; 2018; 6(2):133-143. PubMed ID: 29788899
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of nasal cavity drug delivery efficiency with different nozzles in a 3D printed model.
Fang S; Rui X; Zhang Y; Yang Z; Wang W
PeerJ; 2024; 12():e17227. PubMed ID: 38618567
[TBL] [Abstract][Full Text] [Related]
19. Clotrimazole-loaded nanostructured lipid carrier hydrogels: thermal analysis and in vitro studies.
Ravani L; Esposito E; Bories C; Moal VL; Loiseau PM; Djabourov M; Cortesi R; Bouchemal K
Int J Pharm; 2013 Oct; 454(2):695-702. PubMed ID: 23792467
[TBL] [Abstract][Full Text] [Related]
20. Optimization of artemether-loaded NLC for intranasal delivery using central composite design.
Jain K; Sood S; Gowthamarajan K
Drug Deliv; 2015; 22(7):940-54. PubMed ID: 24512368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
